COVID-19
Metrodora Institute, PrecisionLife to Launch Biomarker-Driven Long COVID, CFS Trials
The organizations aim to validate genotypic diagnostic tests to identify patient risk and inform appropriate biomarker-targeted treatments.
COVID-19 Protection Provided by HLA Genetic Variant, Study Suggests
Using data from bone marrow registry participants, researchers found an HLA variant linked to symptom-free SARS-CoV-2 infection and better immune cell responses.
Armed with a Gates Foundation grant, investigators will use transmitochondrial cybrids to better understand mtDNA's role in infection severity.
Temelimab targets a pathogenic envelope protein, encoded by human endogenous retrovirus-W, which is seen in about one-quarter of long COVID patients.
Although it has seemingly tried to do everything, everywhere, all at once with its immune sequencing technology, Adaptive has sharpened its focus.